You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 10,435,438


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,435,438 protect, and when does it expire?

Patent 10,435,438 protects ZILBRYSQ and is included in one NDA.

This patent has eighty-six patent family members in twenty-eight countries.

Summary for Patent: 10,435,438
Title:Modulation of complement activity
Abstract:The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.
Inventor(s):Hoarty Michelle Denise, Dhamnaskar Ketki Ashok, Elbaum Daniel, Josephson Kristopher, Larson Kelley Cronin, Ma Zhong, Nims Nathan Ezekiel, Ricardo Alonso, Seyb Kathleen, Tang Guo-Qing, Treco Douglas A., Wang Zhaolin, Ye Ping, Zheng Hong, Perlmutter Sarah Jacqueline, Hammer Robert Paul
Assignee:Ra Pharmaceuticals, Inc.
Application Number:US16237893
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,435,438: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 10,435,438, exploring its claims, the patent landscape, and the tools and methods used for such analyses.

Understanding Patent 10,435,438

To begin, let's identify the key elements of the patent in question.

Patent Title and Abstract

The title and abstract provide the first glimpse into what the patent covers. For example, if the patent is titled "Method and System for [Specific Technology]," the abstract will summarize the main invention, its purpose, and its novelty.

Claims

The claims section is the heart of any patent, defining the scope of the invention. There are two types of claims: independent and dependent. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[4].

Patent Claims Analysis

Independent Claims

Independent claims are broad and define the invention in its most general form. For instance, if a patent has an independent claim that describes a "method for processing data," it sets the broad scope of what the invention encompasses.

Dependent Claims

Dependent claims narrow down the invention by adding specific limitations to the independent claims. These claims help to differentiate the invention from prior art and can be crucial in litigation.

Patent Landscape Analysis

What is Patent Landscape Analysis?

Patent landscape analysis, or patent mapping, is a process that uses computer tools and human intelligence to analyze and extract value from vast amounts of patent data. This analysis helps in understanding the entire landscape of a technology domain and provides insights into competitors and market trends[3].

Elements of Patent Landscape Analysis

  • Application Number, Filing Date, and Country: These details help identify patents published in different countries and languages but referring to the same invention.
  • Legal Status: This includes the status of patents such as alive, pending, lapsed, revoked, or expired.
  • Expected Expiry Dates: Knowing when patents are expected to expire aids in decision-making and strategic planning.
  • Patent Trends and Market Developments: This includes information on mergers and acquisitions, in/out-licensing, litigation, and opposition activities.

Tools for Patent Landscape Analysis

USPTO Databases

The U.S. Patent and Trademark Office (USPTO) provides several databases for patent searching, including the Patent Public Search database, which allows full-text searching of patent grants and applications from the U.S. and over 100 other patent offices around the world[4].

Cooperative Patent Classification (CPC)

The CPC database is a powerful tool for finding relevant classification schemes, helping to categorize patents and identify related inventions.

PATENTSCOPE Database

The PATENTSCOPE database, provided by the World Intellectual Property Organization (WIPO), offers access to international Patent Cooperation Treaty (PCT) applications and patent documents from participating national and regional patent offices[4].

Google Patents and Espacenet

Google Patents and the European Patent Office's Espacenet website are additional resources that provide comprehensive patent data, including full-text searches and machine translation capabilities[1].

Historical Context and Prior Art

Historical Patents

For patents like 10,435,438, understanding the historical context involves looking at prior art. Resources such as the "Digest of Patents: 1790 to 1839" and "List of Patents: 1790 to 1847" can provide insights into early inventions and how they have evolved over time[1].

Early Unnumbered Patents

The early unnumbered U.S. patents (1790-1836) can be particularly useful in tracing the evolution of technologies. These patents, sometimes referred to as "X" patents, are listed by patent class, invention title, and issue date[1].

Legal Considerations

Obviousness-Type Double Patenting (ODP)

In cases like the Cellect LLC appeal, the issue of obviousness-type double patenting (ODP) can be critical. ODP occurs when a patent claim is not patentably distinct from an earlier patent claim by the same inventor. This can lead to the invalidation of patent claims, as seen in the Cellect LLC case where claims were found unpatentable over earlier family member patents[2].

Patent Term Adjustment (PTA)

Patent Term Adjustment (PTA) is another important legal consideration. PTA can extend the term of a patent due to delays in the prosecution process. However, as in the Cellect LLC case, the relationship between PTA and the expiration dates of related patents can be complex and impact the validity of the patents[2].

Strategic Implications

Competitor Analysis

Patent landscape analysis helps in identifying competitors and their technological advancements. By analyzing the patents held by competitors, businesses can strategize their own research and development efforts.

Licensing and Litigation

Understanding the patent landscape can also inform licensing strategies and help in anticipating potential litigation. Knowing which patents are about to expire or are currently in dispute can be crucial for business decisions.

Market Trends

Identifying market trends through patent landscape analysis can guide investment and innovation strategies. For instance, a surge in patents in a particular technology area may indicate a growing market demand.

Case Study: Cellect LLC

The Cellect LLC case highlights the complexities of patent law, particularly in relation to ODP and PTA. The case involved multiple related patents with overlapping claims, leading to issues with patent validity. This example underscores the importance of thorough patent landscape analysis and careful management of patent portfolios.

Key Takeaways

  • Patent Claims: The claims section of a patent defines its scope and is crucial for understanding the invention.
  • Patent Landscape Analysis: This analysis provides insights into competitors, market trends, and legal status of patents.
  • Tools and Resources: Utilize USPTO databases, CPC, PATENTSCOPE, Google Patents, and Espacenet for comprehensive patent searches.
  • Legal Considerations: Be aware of issues like ODP and PTA, which can impact patent validity.
  • Strategic Implications: Use patent landscape analysis to inform competitor analysis, licensing strategies, and market trend identification.

FAQs

What is the purpose of patent landscape analysis?

Patent landscape analysis is used to understand the entire landscape of a technology domain, providing insights into competitors, market trends, and the legal status of patents. It helps in extracting valuable legal, business, and technical information from vast amounts of patent data.

How do I search for historical U.S. patents?

Historical U.S. patents can be searched using resources such as the "Digest of Patents: 1790 to 1839" and "List of Patents: 1790 to 1847," available through the Hathi Trust and other archives. Early unnumbered patents (1790-1836) are listed by patent class, invention title, and issue date[1].

What is obviousness-type double patenting (ODP)?

ODP occurs when a patent claim is not patentably distinct from an earlier patent claim by the same inventor. This can lead to the invalidation of patent claims, as seen in cases where claims are found unpatentable over earlier family member patents[2].

How does Patent Term Adjustment (PTA) affect patents?

PTA can extend the term of a patent due to delays in the prosecution process. However, the relationship between PTA and the expiration dates of related patents can be complex and impact the validity of the patents[2].

What tools are available for conducting a patent landscape analysis?

Tools include the USPTO's Patent Public Search database, the Cooperative Patent Classification (CPC) database, the PATENTSCOPE database, Google Patents, and the European Patent Office's Espacenet website[4].

Sources

  1. NYPL Libguides: How to Search for an Historical U.S. Patent.
  2. United States Court of Appeals for the Federal Circuit: In re Cellect.
  3. Sagacious Research: Navigating Technological Domains with Patent Landscape Analysis.
  4. Clemson University Library Guides: Advanced Patent Searching.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,435,438

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ucb Inc ZILBRYSQ zilucoplan sodium SOLUTION;SUBCUTANEOUS 216834-001 Oct 17, 2023 RX Yes Yes 10,435,438 ⤷  Subscribe Y TREATMENT OF GENERALIZED MYASTHENIA GRAVIS (GMG) IN AN ADULT PATIENT WHO IS ANTI-ACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY POSITIVE BY SUBCUTANEOUS ADMINISTRATION OF C5 COMPLEMENT INHIBITOR ZILUCOPLAN ⤷  Subscribe
Ucb Inc ZILBRYSQ zilucoplan sodium SOLUTION;SUBCUTANEOUS 216834-002 Oct 17, 2023 RX Yes Yes 10,435,438 ⤷  Subscribe Y TREATMENT OF GENERALIZED MYASTHENIA GRAVIS (GMG) IN AN ADULT PATIENT WHO IS ANTI-ACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY POSITIVE BY SUBCUTANEOUS ADMINISTRATION OF C5 COMPLEMENT INHIBITOR ZILUCOPLAN ⤷  Subscribe
Ucb Inc ZILBRYSQ zilucoplan sodium SOLUTION;SUBCUTANEOUS 216834-003 Oct 17, 2023 RX Yes Yes 10,435,438 ⤷  Subscribe Y TREATMENT OF GENERALIZED MYASTHENIA GRAVIS (GMG) IN AN ADULT PATIENT WHO IS ANTI-ACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY POSITIVE BY SUBCUTANEOUS ADMINISTRATION OF C5 COMPLEMENT INHIBITOR ZILUCOPLAN ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,435,438

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3154561 ⤷  Subscribe CA 2024 00021 Denmark ⤷  Subscribe
European Patent Office 3154561 ⤷  Subscribe 301275 Netherlands ⤷  Subscribe
European Patent Office 3154561 ⤷  Subscribe PA2024514 Lithuania ⤷  Subscribe
European Patent Office 3154561 ⤷  Subscribe LUC00343 Luxembourg ⤷  Subscribe
European Patent Office 3154561 ⤷  Subscribe 2024C/518 Belgium ⤷  Subscribe
European Patent Office 3154561 ⤷  Subscribe 17/2024 Austria ⤷  Subscribe
Australia 2015274482 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.